Agenus publishes phase 1b data for liver cancer drug combination

May 15, 2026 4:11 PM

Agenus Inc. (NASDAQ: AGEN) announced the publication of Phase 1b clinical trial data for its drug combination botensilimab and balstilimab ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found